Place of angiotensin receptor blockers in antihypertensive therapy

Abstract

The arterial hypertension takes the basic place among the cardiovascular diseases which are a principal cause of death and invalidity. For today the basic group for treatment of an arterial hypertensia remain angiotensin-converting enzyme inhibitors (ACEi). However, according to numerous researches, angiotensin II receptor inhibitors by the efficiency are equal with ACEi, but have the best profile of shipping and provide higher adherence to therapy. One of highly effective, well studied, with considerable demonstrative base of preparations irbesartan.

Keywords

• arterial hypertension
• renin-angiotenzin system
• angiotensin ii receptor inhibitors
• irbesartan